Aducanumab (Anti-Amyloid Beta)
Aducanumab (Anti-Amyloid Beta) (A2588-GRP)
Aducanumab (Anti-Amyloid Beta) is a selective human monoclonal antibody targeting aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.MW :145.5 KD.
View Data Sheet
Products
Description
Aducanumab (Anti-Amyloid Beta) is a selective human monoclonal antibody targeting aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research.MW :145.5 KD.
Specifications
| Manufacturer Cat# | A2588 |
|---|
